Anoectochilus formosanus homogeneous polysaccharide as well as preparation method and application thereof

The preparation of ABP-1a from A. brevis through specific chromatographic processes addresses the need for non-toxic CLI treatments by effectively reducing liver enzyme levels and oxidative stress, improving liver pathology, and alleviating inflammation.

CN119080963APending Publication Date: 2024-12-06FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411286456.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

There is a lack of effective and non-toxic drugs for treating chemical liver injury (CLI) from chemical hepatotoxic substances, which can lead to liver fibrosis and liver cancer if not treated promptly, and existing treatments have significant side effects.

Method used

A method to prepare a uniform polysaccharide ABP-1a from A. brevis through extraction, precipitation, dialysis, ion exchange column chromatography, and gel column chromatography to obtain a polysaccharide with a specific monosaccharide composition and molecular weight, which is then used as a pharmaceutical preparation for resisting chemical liver damage.

Benefits of technology

ABP-1a significantly reduces liver enzyme levels and oxidative stress markers, improves liver pathology, and alleviates inflammation, demonstrating a strong protective effect against chemical liver injury in mice models.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080963A_ABST
    Figure CN119080963A_ABST
Patent Text Reader

Abstract

The invention relates to anoectochilus formosanus homogeneous polysaccharide as well as a preparation method and application thereof, the preparation method comprises the following steps: carrying out water extraction and alcohol precipitation on raw materials to obtain crude polysaccharide, and purifying the crude polysaccharide through TOYOPEARL DEAE-650M anion exchange column chromatography and Sephadex-G100 gel column chromatography to prepare the high-purity anoectochilus formosanus homogeneous polysaccharide ABP-1a. The content of total sugar of the anoectochilus formosanus homogeneous polysaccharide ABP-1a in the extract is 96.38%, the molecular weight of the anoectochilus formosanus homogeneous polysaccharide ABP-1a is 6543 Da, and the monosaccharide is glucose. The method has the advantages of abundant and easily available raw materials, simple and easy process, simple operation, high efficiency, environmental protection and low production cost, and is suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medicines, and in particular to a preparation method and application of a uniform polysaccharide of Rhizoma Cibotii with the function of resisting chemical liver damage. Background Art

[0002] Chemical liver injury (CLI) is liver damage caused by chemical hepatotoxic substances. It is one of the most common types of liver injury in clinical practice. If CLI is not treated effectively in time, it may develop into liver fibrosis, liver failure, and even deteriorate into serious liver diseases such as liver cancer. At present, there is still a lack of CLI treatment drugs that are both highly effective and have no obvious toxic side effects. Therefore, it is of urgent practical significance to find and develop safer anti-liver injury drugs from natural medicinal plants. In recent years, a large number of studies have shown that Chinese medicine polysaccharides are safe, effective, and have few side effects. They have become a hot spot in the research of anti-CLI drugs and have good application prospects.

[0003] Jinliana short-lippeda Anoectochilus brevilabris Fresh or dried whole herb of Lindl. There are few studies on Jinxianlan, and no reports on its anti-chemical liver damage effect. Summary of the invention

[0004] One of the purposes of the present invention is to provide a method for preparing a uniform polysaccharide ABP-1a of A. brevis which has a definite effect of resisting chemical liver damage and has no toxic side effects.

[0005] The second purpose of the present invention is to prepare the above-mentioned A. brevis uniform polysaccharide ABP-1a into a pharmaceutical preparation with resistance to chemical liver damage or a raw material for preparing other drugs against chemical liver damage.

[0006] The above object of the present invention is achieved through the following technical solutions: A method for preparing a uniform polysaccharide ABP-1a from A. scutellaria var. truncatum. The method comprises extracting the polysaccharide from the polysaccharide with water and precipitating the polysaccharide with alcohol to obtain a crude polysaccharide. The crude polysaccharide is dialyzed and then subjected to ion exchange column chromatography and gel column chromatography to obtain the uniform polysaccharide ABP-1a from A. scutellaria var. truncatum. It includes the following specific steps: (1) Extract the short-lipped golden thread orchid with water and reflux, concentrate the filtrate, add ethanol to precipitate, and centrifuge to obtain the precipitate; (2) The precipitate is dissolved in pure water and dialyzed, and the dialyzate is freeze-dried to obtain the crude polysaccharide ABP of A. (3) ABP was dissolved in pure water and then passed through a TOYOPEARL DEAE-650M anion exchange column. Gradient elution was performed using water, 0.2 mol / L NaCl and 0.4 mol / L NaCl solutions, respectively. The polysaccharides in each tube of solution were analyzed by the phenol-sulfuric acid method. The polysaccharide elution curve was plotted with the elution tube number (X) and absorbance A (Y) as the horizontal and vertical coordinates, respectively. The water elution fraction, 0.2 mol / L NaCl elution fraction and 0.4 mol / L NaCl elution fraction were combined according to the elution curve. The water elution fraction was concentrated and freeze-dried to obtain ABP-1; the 0.2 mol / L NaCl elution fraction was concentrated and dialyzed for 48 h (molecular weight cutoff 3000 Da), and then freeze-dried to obtain ABP-2; the 0.4 mol / L NaCl elution fraction was concentrated and dialyzed for 48 h (molecular weight cutoff 3000 Da), and then freeze-dried to obtain ABP-3.

[0007] (4) ABP-1 was dissolved in pure water, chromatographed on a Sephadex-G 100 gel column, and eluted with pure water. The polysaccharides in each tube of solution were analyzed by the phenol-sulfuric acid method, and a polysaccharide elution curve was drawn with the elution tube number (X) and absorbance A (Y) as the horizontal and vertical coordinates, respectively. The eluates with high absorbance peaks in the elution curve were combined, concentrated, and freeze-dried to obtain ABP-1a.

[0008] The monosaccharide composition of the uniform polysaccharide ABP-1a of the short-lipped golden thread orchid of the present invention is glucose, the main chain is composed of α-D-(1→4)-Glcp glycosidic bonds, and the molecular weight is 6543 Da. The content of polysaccharide is calculated as glucose, and the total content of polysaccharide in the uniform polysaccharide ABP-1a of the short-lipped golden thread orchid is 96.38%.

[0009] The advantages of the present invention are: The pharmacodynamics experiments showed that the purified homogeneous polysaccharide ABP-1a can significantly reduce the levels of AKP, LDH, AST and ALT in the serum of mice with CCl4-induced liver injury, reduce the content of MDA in liver tissue, and increase the activity of SOD, CAT and GSH in liver tissue. The results of H&E staining showed that ABP-1a can significantly improve the liver pathological damage of mice with CCl4-induced acute liver injury, significantly reduce liver cell necrosis, and alleviate inflammatory cell infiltration, and has a significant effect on resisting chemical liver injury. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 is a HPGPC chromatogram of ABP and ABP-1a according to one embodiment of the present invention, A: mobile phase; B: ABP-1a; C: ABP; Figure 2UPLC chromatogram of the PMP derivative of the complete acid hydrolysis product of ABP-1a according to one embodiment of the present invention, A. Monosaccharide mixed standard; B. ABP-1a; Note: 1. PMP; 2. Mannose; 3. Rhamnose; 4. Glucuronic acid; 5. Galacturonic acid; 6. Glucose; 7. Galactose; 8. Xylose; 9. Arabinose; Figure 3 is an ABP-1a according to one embodiment of the present invention 1 H NMR spectrum; Figure 4 is an ABP-1a according to one embodiment of the present invention 13 C NMR spectrum; Figure 5 is a HSQC spectrum of ABP-1a according to one embodiment of the present invention; Figure 6 is the HMBC spectrum of ABP-1a according to one embodiment of the present invention; Figure 7 is a COSY spectrum of ABP-1a according to one embodiment of the present invention; Figure 8 is a NOESY spectrum of ABP-1a according to one embodiment of the present invention; Fig. 9 is a repeating structural unit of ABP-1a according to one embodiment of the present invention; Fig.10 The effect of ABP-1a on the levels of AKP, LDH, AST and ALT in the serum of mice with liver damage induced by CCl4 according to one embodiment of the present invention ( ,n=8 ), Note: Compared with the Control group, ## P <0.01; # P <0.05; compared with the model group, ** P <0.01; * P <0.05; Fig.11 The effect of ABP-1a on the levels of MDA, SOD, CAT and GSH in liver tissue of mice with liver damage induced by CCl4 according to one embodiment of the present invention ( , n = 8), Note: Compared with the Control group, ## P <0.01; # P <0.05; compared with the model group, ** P<0.01; * P <0.05; Fig.12 FIG. 1 is the effect of ABP-1a according to one embodiment of the present invention on the pathological morphology of liver tissue in mice with liver damage induced by CCl4 (magnification: ×200). DETAILED DESCRIPTION

[0011] The present invention will be further described below in conjunction with specific embodiments, and the advantages and features of the present invention will become clearer as the description proceeds. However, these embodiments are exemplary only and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the scope of protection of the present invention.

[0012] Example 1 Preparation of ABP-1a, a homogeneous polysaccharide from A. scutellaria The medicinal materials of A. scutellariae were dried at 60℃ to a constant mass, crushed, and the residues were dried. 30 times the weight of pure water was added and refluxed at 100℃ for 4 times, 2 h / time. The water extracts were combined, filtered, and the filtrate was concentrated to a certain volume under reduced pressure. Anhydrous ethanol was added to the ethanol volume concentration of 80%, and the mixture was allowed to stand at 4℃ for 12 h, filtered, and the precipitate was re-dissolved in ultrapure water. The supernatant was dialyzed with a dialysis bag with a molecular weight cutoff of 3000 Da for 48 h, and freeze-dried to obtain the crude polysaccharide (ABP) of A. scutellariae. ABP was dissolved in pure water and then passed through a TOYOPEARL DEAE-650M anion exchange column. Gradient elution was performed with water, 0.2 mol / L NaCl, and 0.4 mol / L NaCl solution, respectively. The polysaccharides in each tube of solution were analyzed by the phenol-sulfuric acid method. The polysaccharide elution curve was plotted with the number of elution tubes (X) and absorbance A (Y) as the horizontal and vertical coordinates, respectively. According to the elution curve, the water elution fraction, 0.2 mol / LNaCl elution fraction, and 0.4 mol / LNaCl elution fraction were combined. The water elution fraction was concentrated and freeze-dried to obtain ABP-1; the 0.2 mol / LNaCl elution fraction was concentrated and dialyzed for 48 h (molecular weight cutoff 3000 Da), and then freeze-dried to obtain ABP-2; the 0.4 mol / LNaCl elution fraction was concentrated and dialyzed for 48 h (molecular weight cutoff 3000 Da), and then freeze-dried to obtain ABP-3. ABP-1 was dissolved in pure water, passed through Sephadex-G 100 gel column chromatography, and eluted with pure water. The polysaccharides in each tube of solution were analyzed by the phenol-sulfuric acid method, and the polysaccharide elution curve was drawn with the elution tube number (X) and absorbance A (Y) as the horizontal and vertical coordinates, respectively. The eluates with high absorbance peaks in the elution curve were combined, concentrated, and freeze-dried to obtain ABP-1a.

[0013] Example 2 Structural Characterization of the Homogeneous Polysaccharide ABP-1a from Anoectochilus brevis The phenol-sulfuric acid method was used to determine the total sugar content of ABP-1a, the HPGPC method was used to detect the purity and relative molecular weight of ABP-1a, the PMP-HPLC method was used to determine the monosaccharide composition of ABP-1a, and the 1D-NMR and 2D-NMR techniques were used to determine the connection mode and connection order of sugar residues in the uniform polysaccharide ABP-1a of A.

[0014] After testing, the total sugar content of the uniform polysaccharide ABP-1a of A. short-lippedus was 96.38%, and the HPGPC chromatogram ( Figure 1 ) showed that ABP-1a presented a single symmetrical peak with a purity greater than 98%. The standard curve of the relative molecular weight of dextran was drawn with the retention time (t) and the logarithmic value of the relative molecular weight of the dextran reference substance with different molecular weights (lgMw) as the horizontal axis (x) and the vertical axis (y). The relative molecular weight of ABP-1a was calculated based on the regression equation log Mw = -2.3486t+40.518 drawn for dextran with different molecular weights M W The PMP-HPLC spectrum showed that the monosaccharide composition of ABP-1a was glucose ( Figure 2 ).

[0015] Figure 3 It is measured by ABP-1a 1 H spectrum. As can be seen from the figure, there are three anomeric hydrogen signals in the anomeric hydrogen region, marked as A1 / B1, C1 and D1 respectively. Figure 4 Measured for ABP-1a 13 C spectrum, and 1 Compared with the H spectrum, the 13 The resolution of the C spectrum will be higher than 1 H spectrum. There are four anomeric carbon signals in the anomeric carbon region, marked as: A1, chemical shift δC 99.61; B1, chemical shift δC 100.02; C1, chemical shift δC 99.78; D1, chemical shift δC 98.59. Based on the anomeric carbon signals, the anomeric hydrogen signals corresponding to A1, B1, C1 and D1 can be calculated based on the HSQC spectrum ( Figure 5 ) determined that the chemical shift of A1 is δH 5.43; the chemical shift of B1 is δH 5.42; the chemical shift of C1 is δH 5.39; the chemical shift of D1 is δH 5.00. Then according to the HMBC spectrum ( Figure 6 ), COSY spectrum ( Figure 7 ) and NOESY spectra ( Figure 8 ) can be used to characterize all sugar residues in ABP-1a.13 C and 1 The H chemical shifts were assigned and the results are shown in Table 1.

[0016] Table 1 ABP-1a 1 H and 13 C chemical shift assignment (ppm) Chemical shift assignment of sugar residue A: 13 In the anomeric carbon region of the C spectrum, the strongest signal is at δC 99.6. From the HSQC spectrum, it can be seen that the corresponding anomeric hydrogen chemical shift is at δH 5.43, which shows that the sugar residue A is in α configuration. The chemical shifts of C-2 are δC 71.5, C-3 are δC 73.2, C-4 are δC 76.8, C-5 are δC 71.1, and C-6 are δC 60.4, and their corresponding protons H-2 are δH 3.67, H-3 are δH 4.01, H-4 are δH 3.68, H-5 are δH 3.65, and H-6 are δH 3.87 / 3.88. Based on HSQC, HMBC and 1 H- 1 H COSY correlation was established. Combined with literature comparison

[50] , determined that the main chain of ABP-1a is →4)-α-D-Glcp-(1→.

[0017] Chemical shift assignment of sugar residue B: 13 From the C spectrum, we can see that δC 100.00 is the chemical shift of the anomeric carbon of sugar residue B. From the HSQC spectrum, we can see that δH 5.42 is the anomeric hydrogen signal of sugar residue B, which shows that sugar residue B is in α configuration. From the COSY spectrum, we can attribute the chemical shifts of other proton signals, that is, the chemical shift of H2 is δH 3.66, the chemical shift of H-3 is δH 3.99, the chemical shift of H-4 is δH 3.68, the chemical shift of H-5 is δH 3.66 and the chemical shift of H-6 is δH 3.68. According to the HSQC spectrum, the cross peaks of H-2 and C-2, H-3 and C-3, H-4 and C-4, H-5 and C-5, H-6 and C-6 were found. The chemical shift of C-2, C-3, C-4, C-5, C-6 and C-6 attributable to sugar residue B was δC 71.4, δC 72.7, δC 76.6, δC 72.9 and δC 67.8. According to the downfield carbon signals at C-4 (δC 76.6) and C-6 (δC 67.8) and literature analysis, residue B of ABP-1a was defined as (→4,6)-α-D-Glcp-(1→).

[0018] Chemical shift assignment of sugar residue C: Another group of abnormal carbon and proton signals at δC 99.8 and δH 5.39 ppm were assigned to C-1 and H-1 of sugar residue C, respectively. Combining the HSQC and HMBC spectra for assignment, it was found that the chemical shifts of C-2 were δC 70.4, C-3 were δC 77.8, C-4 were δC 76.6, C-5 were δC 71.5 and C-6 were δC 60.4. These other five abnormal carbon signals, especially the obvious changes of C-2, C-3 and C-6 signals compared with other residues, indicate that C-3 rather than C-6 may have a sugar connection. According to 1 H- 1 The H COSY spectrum was assigned, and further assignment of 1H signals from H-2 to H-6 was established. Combined with comparative analysis of literature data, it was concluded that the sugar residue C of ABP-1a is (1→3,4)-α-D-Glcp-(1→, which was confirmed by the downfield shift of the C-3 signal at δC 77.8 and the upfield shift of the C-2 signal at δC 70.4.

[0019] Chemical shift assignment of sugar residue D: 13 From the C spectrum, we can see that δC 98.6 is the chemical shift of the anomeric carbon of sugar residue D. From the HSQC spectrum, we can see that δH 5.00 is the anomeric hydrogen signal of sugar residue C, indicating that sugar residue D is also in α configuration. By assigning the cross peaks in the COSY spectrum and combining with the references

[53] According to the information, the chemical shift of H-2 of sugar residue D is δ H 3.62, the chemical shift of H-3 is δ H 3.76, the chemical shift of H-4 is δ H 3.45, the chemical shift of H-5 is δ H 3.71, the chemical shift of H-6a is δ H 3.86 and the chemical shift of H-6b is δ H 3.93. Then the corresponding carbon signals can be found in the HSQC spectrum, the chemical shift of C-2 is δ C 71.4, the chemical shift of C-3 is δ C 73.4, the chemical shift of C-4 is δ C 69.3, the chemical shift of C-5 is δ C 70.00, and the chemical shift of C-6 is δ C 60.4. Combined with the literature

[54] Comparative analysis showed that the sugar residue D of ABP-1a is α-Glcp-(1→.

[0020] The HMBC spectrum and NOESY spectrum can give C / H long-range correlation signals and H / H long-range correlation signals for ABP-1a, thereby inferring the connection order of each sugar residue in ABP-1a. Figure 6As shown in the figure, the signals of H-1 (δ 5.43) and C-4 (δ 76.6) of sugar residue A are coupled, and those of H-4 (δ 3.68) and C-1 (δ 99.6) are coupled, indicating that the main chain of ABP-1a is composed of →4)-α-Glcp-(1→. The coupling of H1 (δH 5.42 ppm) of sugar residue B with C4 (δC 76.8) of sugar residue A and H4 (δH 3.68 ppm) of sugar residue A with C1 (δC 100.0) of sugar residue B means the existence of the fragment [→4,6)-α-DGlcp-(1→4)-α-D-Glcp-(1→]. At δH 3.99 / δC 100.0 Although weak, the signals observed at ppm extend from H-3 of sugar residue B to C-1 of sugar residue C, indicating that sugar residues 1,3,4-α-D-Glcp are associated with the C-4 position of 1,4,6-α-D-Glcp and the branch is associated with the C-6 position. The coupling of H1 of sugar residue A (δH 5.43 ppm) to C4 of sugar residue C (δC 76.6) and the downfield shift of C-3 (δC 77.8) indicate the presence of [→4)-α-D-Glcp-(1 → 3,4)-α-D-Glcp-(1 →], with the terminal 1-α-D-Glcp connected to O-3 of 1,3,4-α-D-Glcp. Taken together, the results suggest that [→4)-α-D-Glcp-(1 → 3,4)-α-D-Glcp-(1 → 4,6)-α-D-Glcp-(1 → 4) -α-D-Glcp-(1→] main chain sequence branches at O-3 and O-6. Combined with literature data analysis, a repeating unit structure of ABP-1a is obtained as follows Fig. 9 shown.

[0021] Example 2 Experiment on the Anti-chemical Liver Injury Effect of ABP-1a from the Homogeneous Polysaccharide of A. brevis After 5 days of adaptive feeding, male ICR mice were randomly divided into normal control group (Control), CCl4 model group (CCl4), bifendate group (20 mg / kg, BFD), high-dose group of ABP-1a of A. serrata and low-dose group of ABP-1a of A. serrata (300, 100 mg / kg), with 8 mice in each group. The mice in each treatment group were given the corresponding drugs for 12 consecutive days, once a day, and the gavage volume was 10 mL / kg. The control group and the CCl4 group were gavaged with an equal volume of 0.5% sodium carboxymethyl cellulose solution. 2 hours after the last administration, the mice in the other groups except the control group were intraperitoneally injected with 0.2% CCl4 peanut oil solution (10 mL / kg) to induce acute liver injury, and the mice in the control group were intraperitoneally injected with an equal volume of peanut oil. Subsequently, the mice were fasted for 16 hours, during which they could drink water freely. After the experiment, serum was obtained by eye sampling and centrifugation at 4500 r / min for 15 min. Then, the mouse liver was quickly removed, and a part of the left lobe of the liver was fixed in 4% paraformaldehyde solution, and the remaining liver tissue was stored in a -80 ℃ refrigerator for other index detection. The levels of alkaline phosphatase (AKP), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) in mouse serum were determined according to the instructions of the kit; the liver tissue of the mouse was taken, and the levels of liver malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) were determined according to the instructions of the kit; the left lobe of the liver was fixed in 4% paraformaldehyde, dehydrated, paraffin-embedded, sectioned, and stained with hematoxylin-eosin (HE), and the pathological changes of liver tissues of mice in each group were observed under a microscope.

[0022] like Fig.10 As shown in Figure 2, compared with the Control group, the serum levels of AKP, LDH, AST and ALT in the CCl4 group were significantly increased ( P <0.01). Compared with the CCl4 group, the ABP-1a high-dose group could significantly reduce the levels of serum AKP, LDH, AST and ALT ( P <0.01, P <0.05). The above results indicate that ABP-1a has a significant protective effect on CCl4-induced liver tissue damage in mice. Fig.11 As shown, compared with the Control group, the MDA level in the liver tissue of the CCl4 group was significantly increased ( P <0.01), SOD and CAT activities were significantly decreased ( P <0.01, P <0.05), and GSH levels were also significantly decreased ( P<0.01). Compared with the CCl4 group, the ABP-1a high-dose group could significantly reduce the MDA level ( P <0.01, and increased the levels of SOD, CAT and GSH ( P <0.01, P <0.05). The results showed that ABP-1a could enhance the antioxidant capacity of mouse liver.

[0023] HE staining results Fig.12 As shown, the high-dose ABP-1a group can significantly improve the liver pathological damage of mice with CCl4-induced acute liver injury, significantly reduce liver cell necrosis, alleviate inflammatory cell infiltration, and has a significant anti-chemical liver injury effect.

[0024] The above description is only a preferred embodiment of the present invention. All equivalent changes and modifications made according to the scope of the patent application of the present invention should fall within the scope of the present invention.

Claims

1. A homogeneous polysaccharide ABP-1a from Anoectochilus brevis, characterized by: The homogeneous polysaccharide ABP-1a has a total sugar content of 96.38%, a molecular weight of 6543 Da, a monosaccharide composition of glucose, and a main chain composed of α-D-(1→4)-Glcp glycosidic bonds.

2. The method for preparing the uniform polysaccharide ABP-1a from Anoectochilus brevis according to claim 1, characterized in that: The crude polysaccharide of A. scutellaria was obtained by water extraction and alcohol precipitation. The crude polysaccharide was dialyzed and then subjected to ion exchange column chromatography and gel column chromatography to obtain the uniform polysaccharide ABP-1a of A. scutellaria.

3. The method for preparing the uniform polysaccharide ABP-1a from Anoectochilus brevis according to claim 2, characterized in that: The following steps are involved: (1) Extract the short-lipped golden thread orchid with water and reflux, concentrate the filtrate, add ethanol to precipitate, and centrifuge to obtain the precipitate; (2) The precipitate was dissolved in pure water and dialyzed, and the dialyzate was freeze-dried to obtain the crude polysaccharide ABP of A. (3) ABP was dissolved in pure water and then passed through a TOYOPEARL DEAE-650M anion exchange column. Gradient elution was performed using water, 0.2 mol / L NaCl, and 0.4 mol / L NaCl solutions, respectively. The water elution fraction was concentrated and freeze-dried to obtain ABP-1. (4) ABP-1 was dissolved in pure water and purified by Sephadex-G 100 gel column chromatography to obtain the homogeneous polysaccharide ABP-1a of A.

4. Use of the homogeneous polysaccharide ABP-1a of A. brevis as claimed in claim 1 in the preparation of a drug for resisting chemical liver damage.